药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tolazamide
Efonidipine
The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Saquinavir.
Tolazamide
Lurasidone
The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Saquinavir.
Tolazamide
Pasireotide
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Saquinavir.
Tolazamide
Orphenadrine
The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Saquinavir.
Tolazamide
Mequitazine
The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Saquinavir.
Tolazamide
Felbamate
The risk or severity of QTc prolongation can be increased when Felbamate is combined with Saquinavir.
Tolazamide
Gallopamil
The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Saquinavir.
Tolazamide
Hydroxychloroquine
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Saquinavir.
Tolazamide
Chlorprothixene
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Saquinavir.
Tolazamide
Celiprolol
The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Celiprolol.
Tolazamide
Metoclopramide
The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Metoclopramide.
Tolazamide
Delafloxacin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Saquinavir.
Tolazamide
Lidoflazine
The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Saquinavir.
Tolazamide
Bencyclane
The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Saquinavir.
Tolazamide
Tetrahydropalmatine
The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Saquinavir.
Tolazamide
Rupatadine
The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Saquinavir.
Tolazamide
Lacidipine
The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Saquinavir.
Tolazamide
Aranidipine
The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Saquinavir.
Tolazamide
Pinaverium
The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Saquinavir.
Tolazamide
Trimebutine
The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Saquinavir.